Does the Incremental Shuttle Walk Test Predict the Development of a

Status Completed

Clinical Trial Summary

The purpose of this study was to assess the predictive value of the incremental shuttle walk test on rates of hospital acquired pneumonia for patients undergoing oesophagectomy.

Clinical Trial Description

Field tests to objectively measure functional capacity are becoming of greater importance when looking to assess an individual's fitness for surgery. One such field test is the incremental shuttle walk test (ISWT). An externally paced, maximal excursion test, the ISWT is a simple and easily reproducible test that is widely used within cardiac and pulmonary populations and shown to correlate well with Vo2 mas on a cardiopulmonary exercise test. Previous studies looking at the benefit of the ISWT in predicting post-operative outcomes within the oesophagastric population have demonstrated that walking less than 350 meters has been associated with significantly higher rates of mortality at 30 days and 3 years. No correlation between ISWT and postoperative respiratory complications in this surgical population has been previously reported.

This study aims to assess whether walking <350 meters on an ISWT predicts the development of hospital acquired pneumonias following an elective oesophagectomy ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04440124
Study type	Observational
Source	University Hospital Birmingham NHS Foundation Trust
Contact
Status	Completed
Phase
Start date	December 1, 2017
Completion date	February 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05685862` - Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric Conduit
Recruiting	`NCT01795768` - Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours	Phase 2
Completed	`NCT05266300` - Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Recruiting	`NCT03978377` - Cardiopulmonary Toxicity of Thoracic Radiotherapy
Active, not recruiting	`NCT03653052` - Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab	Phase 2
Recruiting	`NCT05489250` - The PLATON Network
Recruiting	`NCT04484636` - PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)	N/A
Terminated	`NCT01795976` - NY-ESO-1 T Cells in OG Cancer	Phase 2
Recruiting	`NCT01843829` - A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer	Phase 2
Completed	`NCT02382237` - Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition	N/A
Completed	`NCT01915693` - ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study	Phase 3
Recruiting	`NCT04517448` - Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
Recruiting	`NCT04232735` - Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)	N/A
Recruiting	`NCT05642819` - REVOLUTION Surgery (REVOLUTION Surgery)
Recruiting	`NCT04001478` - Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
Recruiting	`NCT02741856` - Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation	Phase 2/Phase 3
Not yet recruiting	`NCT05600608` - Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome	N/A
Recruiting	`NCT04481256` - TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY	N/A
Recruiting	`NCT05057013` - HMBD-001 in Advanced HER3 Positive Solid Tumours	Phase 1/Phase 2
Not yet recruiting	`NCT06046846` - Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer	N/A

Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms